Al Azhar University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Cairo Egypt (1961)

Organization Overview

First Clinical Trial
2004
NCT00624871
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Abou el kheir, Wael, M.D. M.Sc. | Ahmed A. H. Abdellatif | Alazhar faculty of medicine | Alazhar University | Al-Azhar University | ALAZHAR UNIVERSITY | Al-Azhar University, Faculty of Dental and Oral Medicine (Girls Branch) | Al-Azhar University, Faculty of medicine for boys | Al-Azhar University, Faculty of Medicine for boys (Cairo), Departments of OBS/GYN | Al-Azhar Universiy | Assistant professor of obstetrics and gynecology faculty of medicine Alazhar university Cairo | Azhar university | Bakry, Sayed , phD. M.Sc. | Deaprtment of Pediatric Surgery School of Medicine Al Azhar University | Department of Clinical Pathology , School of Medicine, Al Azhar University | Department of Laboratory Medicine, Al Azhar University-Gaza, Gaza Strip, Palestine | Department of Obstetrics and Gynecology, Al Azhar university, Egypt | Department of Pediatric Surgery , School of Medicine, Al Azhar University | Department of Pediatric Surgery, School of Medicine, Al Azhar University | Department of Urology, School of Medicine, Al Azhar University | Egymedicalpedia | Egyptian Biomedical Research Network | El-Azhar University | Endodontist, Faculty of Dental Medicine for Girls, Al-Azhar University | Faculty of dental medicine Al-Azhar university Assiut Branch | Faculty of Dental Medicine for Girls | Faculty of Medicine, El-Azhar University | Fixed Prosthodontist, Faculty of Dental Medicine for Girls, Al-Azhar University | Gabr, Hala , M.D. M.Sc. | Hassan , Hosny , M.D. M.Sc | Higazy , Hasan M.D. M.Sc | Internal Medicine dept.-Alazhar University | Ismail , Mahmoud M.D. M.Sc | Laboratory of Molecular Biology , School of Science, Al Azhar University | lecturer, faculty of dental medicine, Al-Azhar university | MOHAMED BEHERY | Pedodontist, Faculty of Dental Medicine for Girls, Al-Azhar University | Professor of Endodontics AL-Azhar university | Professor of Pharmacology and Toxicology Faculty of Medicine, Al-Azhar University | Samour , Hany M.D. M.Sc | Sayed Bakry

Active Ingredients

Drugs in Phase 4 Trials (21)

a23187 (1 trial)

alprostadil (prostin) (1 trial)

amoxicillin (2 trials)

beta-glucans (1 trial)

cetrorelix (cetrotide) (1 trial)

clarithromycin (biaxin) (2 trials)

colistin (1 trial)

cyclophosphamide (cytoxan) (1 trial)

daclatasvir (daklinza) (1 trial)

ledipasvir (Harvoni) (1 trial)

meropenem (merrem) (1 trial)

methylprednisolone (medrol) (2 trials)

metronidazole (flagyl) (2 trials)

mycophenolate (myfortic) (1 trial)

omeprazole (prilosec) (2 trials)

recombinant human choriogonadotropin alfa (Ovidrel) (3 trials)

sodium fluoride (2 trials)

sofosbuvir (sovaldi) (1 trial)

somatropin (protropin) (1 trial)

tigecycline (tygacil) (1 trial)

tranexamic acid (cyklokapron) (2 trials)

Drugs in Phase 3 Trials (8)

acetylcysteine (mucomyst) (1 trial)

calcium hydroxide (2 trials)

dexmedetomidine (precedex) (1 trial)

doxycycline (vibramycin) (1 trial)

honey (2 trials)

moxifloxacin (avelox) (1 trial)

nitazoxanide (alinia) (2 trials)

sodium bicarbonate (1 trial)

Drugs in Phase 2 Trials (11)

allogeneic adipose derived mesenchymal stem cell (1 trial)

autologous mesenchymal stem cells (2 trials)

autologous skeletal myoblast (1 trial)

bone marrow derived mesenchymal stem cells (1 trial)

cissus (1 trial)

digoxin (lanoxin) (1 trial)

lactulose (cephulac) (1 trial)

oxytocin (syntocinon) (2 trials)

rifaximin (xifaxan) (1 trial)

stem cells (4 trials)

ursodeoxycholic acid (1 trial)

Drugs in Phase 1 Trials (10)

benzydamine (1 trial)

cetuximab (erbitux) (1 trial)

dexamethasone (1 trial)

ginkgo biloba (1 trial)

glucosamine (1 trial)

lactose (1 trial)

pomegranate (1 trial)

silver nanoparticles (1 trial)

veldoreotide (1 trial)

yinhsing (1 trial)

Drugs in Other Trials (17)

alpha-lipoic acid (1 trial)

carbetocin (1 trial)

filgrastim (neupogen) (2 trials)

fluoroquinolone (1 trial)

grape seed extract (1 trial)

green tea (1 trial)

hesperidin (1 trial)

hyaluronic acid (1 trial)

ibuprofen (motrin) (1 trial)

licorice (1 trial)

misoprostol (cytotec) (1 trial)

miswak (1 trial)

propolis (1 trial)

silver diammine fluoride (1 trial)

theobromine (1 trial)

vitamin c (1 trial)

vitamin d (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aggression (Phase 4)

Aggressive Periodontitis (Phase 4)

Alveolitis, Extrinsic Allergic (Phase 4)

Azoospermia (Phase 2)

Bacterial Infections (Phase 1)

Bladder Exstrophy (Phase 2)

Blood Loss, Surgical (Phase 2)

Brain Diseases (Phase 2)

Breast Neoplasms (Phase 1)

Chronic Periodontitis (Phase 1)

Colonic Neoplasms (Phase 1)

Communicable Diseases (Phase 4)

Dental Pulp Necrosis (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Diabetic Nephropathies (Phase 3)

Diastasis, Bone (Phase 2)

Enuresis (Phase 2)

Helicobacter Infections (Phase 3)

Hemorrhage (Phase 4)

Hepatic Encephalopathy (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hypersensitivity (Phase 4)

Infections (Phase 4)

Infertility (Phase 4)

Infertility, Female (Phase 4)

Infertility, Male (Phase 2)

Ischemia (Phase 4)

Kidney Diseases (Phase 3)

Klebsiella Infections (Phase 4)

Lupus Nephritis (Phase 4)

Macular Degeneration (Phase 2)

Menopause, Premature (Phase 2)

Necrosis (Phase 3)

Nephritis (Phase 4)

Ovarian Hyperstimulation Syndrome (Phase 4)

Periodontitis (Phase 4)

Pneumonia (Phase 4)

Postoperative Hemorrhage (Phase 2)

Postpartum Hemorrhage (Phase 4)

Premature Birth (Phase 2)

Primary Ovarian Insufficiency (Phase 2)

Skin Diseases (Phase 1)

Skin Neoplasms (Phase 1)

Syndrome (Phase 4)

Tinea (Phase 1)

Tinea Pedis (Phase 1)

Urinary Incontinence (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 62
  • # of Trial APIs: 67